IMMUCELL CORP /DE/
ICCC · In Vitro and in Vivo Diagnostic Substances
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
te Boekhorst Paul Francis Olivier: Form 4
Insider disclosure · Filed · Report period 18 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- ICCC · 452525306 - COM PAR
Company details and SEC sources
CIK 0000811641 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- ICCC on Nasdaq
- SEC industry group
- In Vitro and in Vivo Diagnostic Substances (Office of Life Sciences)
- Business address
- 56 Evergreen Dr, Portland, ME, 04103
- Incorporated in
- DE
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields